Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. G. Nazarkina"'
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 19-25 (2020)
Introduction. Cardiovascular diseases are the leading cause of morbidity and mortality worldwide, with heart rhythm disorders accounting for a significant proportion of them. Atrial fibrillation (AF) is an arrhythmia that poses a risk of thromboembol
Externí odkaz:
https://doaj.org/article/b0c23ab921c04ff2aa1c736daeb7aab1
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 7, Pp 67-72 (2018)
Aim. To analyze the results of 5-year follow-up of the paroxysmal atrial fibrillation patients (PAF) taking antiarrhythmic therapy (AAT)Material and methods. Patients (n=500) were selected to 11 groups: I — healthy, II — controls, III-XI — PAF
Externí odkaz:
https://doaj.org/article/e8b8c67bded44d8ba8f299c329a33196
Effects of lappaconitine hydrobromide on qt interval in patients with paroxysmal atrial fibrillation
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 118-120 (2018)
84 patients aged 40 to 70 years received Holter ECG monitoring to determine the values of QT’interval measurement. All patients were divided into 4 groups: group 1 – 24 healthy patients, group 2 – (n = 24) patients with ischemic heart disease (
Externí odkaz:
https://doaj.org/article/731725d49d284020949ad5d31df767c6
Effects of lappaconitine hydrobromide on qt interval in patients with paroxysmal atrial fibrillation
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 118-120 (2018)
84 patients aged 40 to 70 years received Holter ECG monitoring to determine the values of QT’interval measurement. All patients were divided into 4 groups: group 1 – 24 healthy patients, group 2 – (n = 24) patients with ischemic heart disease (